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Adenomyoepithelioma (AME) is a rare benign tumor composed of myoepithelial cells (MECs) which are located beneath the 
epithelial cells of exocrine glands, especially in breast and salivary glands. These tumor cells show biphasic proliferation of 
epithelial and MECs. Malignant AME is characterized by distant metastasis, local recurrence, cytologic atypia, high mitotic 
activity and infiltrating tumor margins. A 51-year-old woman presented with an 8 months growth in the left breast. She un-
derwent core-needle biopsy and consecutively mammotome assisted biopsy at a local clinic. After resection, she complained 
about re-growing remnant lesion and a newly developed solid mass in the right breast. Finally, the remnant mass in the left 
breast was diagnosed with myoepithelial carcinoma. Concurrently, contralateral breast mass was diagnosed with invasive 
micropapillary carcinoma. Herein we report an unusual case of synchronous myoepithelial carcinoma and invasive micro-
papillary carcinoma of the breast with a review of literatures.
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INTRODUCTION
Adenomyoepithelioma (AME) of the breast is an un-
common tumor characterized by dual epithelial and 
smooth muscle differentiation of tumor cells [1]. Breast tu-
mors with myoepithelial differentiation are rare but in 
salivary glands, more common. Sarkar and Lallenbach [2] 
were first described about various amounts of my-
oepiepithelial cells with the degree of differentiation of 
various breast tumors in 1966. Hamperl [3] was first re-
ported to AME of the breast in 1970. According to many re-
ports up to the present, it can demonstrate pure my-
oepithelial or epi-myoepithelial differentiation of benign 
and malignant breast tumors [1-3]. Most of the my-
oepithelioma or AME have been considered to be benign. 
However, malignant transformation of tumor is charac-
terized by infiltrating tumor margins, atypical cytologic 
change, brisk of mitotic figures, tumor necrosis and rarely 
can be distantly metastasized. 
According to World Health Organization, myoepithe-
lial lesions of the breast can be classified as myoepi-
theliosis, adenomyoepithelial adenosis, AME and malig-
nant myoepithelioma (Table 1) [4]. We report herein on a 
case of synchronous myoepithelial carcinoma arising in Sun Young Kwon, et al.
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Table 1. World Health Organization Classification of myoepi-
thelial lesions of the breast
1. Myoepitheliosis
  a. Intraductal
  b. Periductal
2. Adenomyoepithelial adenosis
3. Adenomyoepithelioma
  a. Benign
  b. With malignant changes (specify the subtype)
   ㆍMyoepithelial carcinoma arising in an adenomyoepithelioma
   ㆍEpithelial carcinoma arising in an adenomyoepithelioma
   ㆍMalignant epithelial and myoepithelial components
   ㆍSarcoma arising in adenomyoepithelioma
   ㆍCarcinosarcoma arising in adenomyoepithelioma
4. Malignant myoepithelioma (myoepithelial carcinoma)
Fig. 1. (A) Right mammogram showed a spiculated and hete-
rogenous nodule without a focal lesion or microcalcification. (B) 
Left mammogram demonstrated a lobulated and iso-density 
nodule. (C) Preoperative ultrasonogram of the left breast revealed 
a 1.0 cm sized inhomogeneous, irregular marginated and 
hypoechoic mass.
AME and invasive micropapillary carcinoma in both 
breasts. 
CASE REPORT
A 51-year-old woman presented a re-growing remnant 
mass in the lower central area of left breast, which had al-
ready been resected with a mammotome assisted biopsy 6 
months ago. Initially, the tumor was recognized as fi-
broepithelial tumor with fibromatosis. As time went by, 
the remnant mass started re-growing in the left breast and 
a newly developed solid mass in the upper outer quadrant 
of the right breast was found. Her past medical history or 
family history of breast cancer was unremarkable. 
Mammography showed a 0.9 cm sized spiculated, hetero-
genous nodule at lower central portion of the right breast 
(Fig. 1A). Also a 1.0 cm sized lobulated, iso- density nod-
ule at upper outer quadrant of the right breast was noticed 
(Fig.1B). On ultrasound examination, a 1.0 cm sized in-
homogeneous, irregular marginated and hypoechoic 
mass was located at the 5 o’clock direction of the left breast 
(Fig. 1C) and a 0.9 cm sized multilobulated, heterogenous 
and hypoechoic mass at 9 o’clock direction of the right 
breast. Breast conserving surgery with sentinel lymph 
node biopsy was performed for the left breast mass. At a 
same time, wide excision was executed for the right breast 
mass. Clear resection margins and no evidence of tumor 
metastasis in the sentinel lymph node were found in the 
submitted specimens. Myoepithelial carcinoma and in-
vasive micropapillary carcinoma were found in the left 
and right breast, respectively. 
Grossly, the tumor mass from the left breast showed a 
relatively well-demarcated, multinodular, pale tan to 
white, and solid consistency with partially infiltrating 
margins. 
Microscopically, the tumor from the left breast was com-
posed of a central lesion with glandular epithelial lined 
spaces with increased clear changed myoepithelial cells 
and surrounding predominantly atypical spindle cells at 
the left lower corner (Fig. 2A). At the high power field of 
light microscopy, the atypical tumor cells showed round to 
spindle, hyperchromatic and pleomorphic nuclei with rel-Myoepithelial carcinoma of the breast
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Fig. 2. Microscopic findings of the left breast mass (A-C) and the right breast mass (D). (A) The central lesion of the left breast mass 
demonstrated adenomyoepithelioma with atypical spindle cells at the left lower corner (H&E, x100). (B) The atypical spindle tumor cells 
showed round to spindle, hyperchromatic and pleomorphic nuclei with relatively abundant eosinophilic cytoplasm (H&E, x400). (C) 
Atypical mitotic figure (arrow) was found (H&E, x400). (D) Invasive micropapillary carcinoma was identified in the right breast (H&E, x200). 
atively abundant eosinophilic cytoplasm (Fig. 2B). Atypi-
cal mitotic figures were easily found throughout the tu-
mor and up to 8 mitoses were counted in 10 high-power 
fields (Fig. 2C). The right breast mass consisted of small 
clusters of tumor cells within the clear stromal spaces (Fig. 
2D). 
Immunohistochemically, spindle tumor cells were dif-
fusely positive for smooth muscle actin (Fig. 3A), calponin 
(Fig. 3B), p63 (Fig. 3C) and pancytokeratin (Fig. 3D). The 
labeling index of Ki-67 at the peripheral portion of mass 
was more than 40%. On the basis of the histological and 
immunohistochemical results, we considered this case as a 
synchronous myoepithelial carcinoma arising in AME 
and invasive micropapillary carcinoma in both breasts.
DISCUSSION
AME of the breast is characterized by microscopically 
biphasic proliferation of epithelial and myoepithelial cells. 
The AME of breast is a very rare tumor that was already re-
ported in 1970 [3]. The majority of AME are benign, but 
malignant transformation may occur in AME. Both benign 
and malignant AME are inclined to local recurrence after 
surgery and may even recur several years after the initial 
surgery [5,6]. The guidelines of malignant AME have been Sun Young Kwon, et al.
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Fig. 3. Myoepithelial carcinoma revealed diffuse strong reactivity for smooth muscle actin (A, immunohistochemical stain, x200), calponin 
(B, immunohistochemical stain, x200), p63 (C, immunohistochemical stain, x200) and pan-cytokeratin (D, immunohistochemical stain, x200).
not established yet. However we can use the term ‘malig-
nant AME’ that has infiltrating margins, markedly in-
creased mitotic counts and distinctly cytologic atypia in 
case of not having definite metastasizing evidence [7]. 
Also distant metastasis and local recurrence are the most 
obvious evidences of malignancy. Subsequently, malig-
nant transformation of AME can be divided into three dif-
ferent types according to the main malignant cell types: 1) 
completely epithelial type; 2) malignant spindle cell type; 
or 3) both epithelial and myoepithelial type. Malignant ep-
ithelial carcinoma arising AME is similar to infiltrating 
ductal carcinoma, mucoepidermoid carcinoma or adeno-
squamous carcinoma. Myoepithelial carcinoma or malig-
nant myoepithelioma is purely composed of infiltrating 
myoepithelial cells with predominantly spindle features. 
Microscopically, myoepithelial carcinoma shows in-
filtrating patterned spindle tumor cells with prominent 
cytologic atypia, increased mitotic activity (more than 
3-4/10 HPF) and definitely infiltrating tumor borders. On 
immunohistochemistry, spindle tumor cells represent 
strong positivity of myoepithelial markers, such as 
smooth muscle actin, calponin, S-100 or p63, and of epi-
thelial markers, such as cytokeratin or epithelial mem-
brane antigen. 
Treatment of malignant AME or myoepithelial carcino-
ma has not been established yet except only complete sur-
gical resection because of the rarity of this tumor. Up to 
date, several cases of local recurrence or metastasis have 
been reported so myoepithelial carcinoma should be care-
fully examined and needed to close follow up. The effec-Myoepithelial carcinoma of the breast
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tiveness of adjuvant Tamoxifen therapy has not come out.
The differential diagnosis of myoepithelial carcinoma 
should be included spindle cell carcinoma, fibromatosis 
and variety of myofibroblastic tumors. The obviously 
atypical spindle cells which show positivity of myoepi-
thelial and epithelial markers with infiltrating margins are 
helpful in distinguishing from the spindle cell carcinoma 
and myofibroblastic tumors. Our case showed also bipha-
sic pattern of immunohistochemistry of strong positivity 
for myoepithelial markers, such as smooth muscle actin, 
calponin, p63, and for epithelial marker, such as pan- 
cytokeratin. Also it demonstrated definite infiltrating tu-
mor margins with high mitotic rates (4-5/10 HPF) and 
prominent cytologic atypia. So it could be diagnosed with 
myoepithelial carcinoma. Also there was a central lesion 
which showed biphasic proliferation of inner epithelilal 
and outer myoepithelial cells which could be diagnosed 
with AME. Consequently, our case is a myoepithelial car-
cinoma arising in AME. Interestingly, in our case, a con-
tralateral invasive micropapillary carcinoma was found. 
Han et al. [8] researched molecular abnormalities of ma-
lignant AME and reported the point mutation of p53 gene 
in this myoepithelial cells, but not in intraluminal epi-
thelial cells or adjacent normal ductal epithelium. Also 
Jones et al. [9] were performed comparative genomic hy-
bridization (CGH) analysis on a malignant AME case in 
another study. Furthermore, Angèle et al. [10] have also re-
ported that p53 protein was negative in benign my-
oepithelial lesions but overexpressed in 44.4% of malig-
nant myoepithelial tumors of the breast. Recently some 
molecular studies of AME have been trying to identify the 
molecular pathway of tumorigenesis of AME, but due to 
the rarity of AME or malignant AME, the pathway has not 
been established yet.
In conclusion, our case is a rare case of myoepithelial 
carcinoma arising in AME with contralateral invasive mi-
cropapillary carcinoma. Despite the definite diagnosis of 
malignant AME can be possible throughout various im-
munohistochemistry, pathologists who are unaware of 
myoepithelial lesions can make a misdiagnosis of malig-
nant AME. Finally, in case of malignant AME or malignant 
myoepithelial tumors, close follow up and in some cases, 
adequate further treatment with adjuvant chemotherapy 
or radiotherapy should be considered.  
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